Show
Sort by
-
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
-
Priming of cytotoxic T lymphocyte responses by dendritic cells: induction of potent anti-tumor immune responses
-
- Journal Article
- A1
- open access
Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo
-
Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy
-
Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors
-
Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines
-
Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols
-
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy